Monte Rosa Therapeutics
GLUE
GLUE
104 hedge funds and large institutions have $423M invested in Monte Rosa Therapeutics in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
61% more capital invested
Capital invested by funds: $264M → $423M (+$160M)
28% more funds holding
Funds holding: 81 → 104 (+23)
18.19% more ownership
Funds ownership: 81.07% → 99.26% (+18%)
Holders
104
Holding in Top 10
3
Calls
$2.21M
Puts
$162K
Top Buyers
| 1 | +$39.2M | |
| 2 | +$19.2M | |
| 3 | +$14.8M | |
| 4 |
BlackRock
New York
|
+$6.51M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.32M |
Top Sellers
| 1 | -$10M | |
| 2 | -$7.6M | |
| 3 | -$3.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.64M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$2.09M |